COMMUNIQUÉS West-GlobeNewswire

Vivos Therapeutics Reports Significant Revenue Growth During the Third Quarter 2025
19/11/2025
Financial results highlighted by 78% sequential quarter over quarter revenue growth, showing the impact of the first full quarter of Sleep Center of Nevada operations Management to host conference call today at 5:00 pm [...]
ZyVersa Therapeutics Reports Third Quarter 2025 Financial Results
19/11/2025
ZyVersa is advancing a therapeutic development pipeline with multiple programs built around its two proprietary technologies – Cholesterol Efflux Mediator VAR 200 for treatment of kidney diseases, and Inflammasome ASC [...]
EYLEA HD® (aflibercept) Injection 8 mg Approved by FDA for the Treatment of Macular Edema Following Retinal Vein Occlusion (RVO) and for Monthly Dosing Across Approved Indications
19/11/2025
First and only FDA-approved treatment for RVO indicated for up to every 8-week dosing after an initial monthly dosing period Monthly dosing option in all approved indications provides greater dosing flexibility for more [...]
Ceribell to Participate in the Piper Sandler 37th Annual Healthcare Conference
19/11/2025
SUNNYVALE, Calif., Nov. 19, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological [...]
SynCardia Completes First In Vivo Implantations of Next-Generation Emperor Total Artificial Heart
19/11/2025
Significant milestone reached in advancing a driverless total artificial heart, strengthening Picard Medicals leadership in total artificial heart technology TUCSON, Ariz., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Picard [...]
OPKO Health to Participate in the Piper Sandler 37th Annual Healthcare Conference
19/11/2025
MIAMI, Nov. 19, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq: OPK) announced today that management will be participating in the Piper Sandler 37 th Annual Healthcare Conference, being held December 2-4, 2025 at [...]
Meihua International Announces 1-For-100 Reverse Share Split
19/11/2025
YANGZHOU, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Meihua International Medical Technologies Co., Ltd. (“Meihua” or the “Company”) (Nasdaq: MHUA), reputable manufacturer and provider of Class I, II, and III disposable medical [...]
ImPact Biotech to Present Updated Interim Phase 3 Data from ENLIGHTED Study of Padeliporfin VTP in Low Grade UTUC at SUO 2025
19/11/2025
TEL AVIV, Israel, Nov. 19, 2025 (GLOBE NEWSWIRE) -- ImPact Biotech, a clinical-stage biotechnology company focused on developing Padeliporfin vascular targeted photodynamic (VTP) therapy to treat a range of solid tumors [...]
Carlsmed, Inc. To Participate in the Piper Sandler 37th Annual Healthcare Conference
19/11/2025
CARLSBAD, Calif., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), today announced that Mike Cordonnier, Chairman and CEO of Carlsmed, will be presenting at the 37th Annual [...]
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
19/11/2025
PALO ALTO, Calif., Nov. 19, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, today announced that on [...]
Patriot Mobile Named SoldierStrong’s 2025 Corporate Recipient of the Annual Commitment to Service Award
19/11/2025
STAMFORD, Conn., Nov. 19, 2025 (GLOBE NEWSWIRE) -- SoldierStrong, the national nonprofit committed to delivering revolutionary medical technologies to America’s veterans, is proud to announce Patriot Mobile as the 2025 [...]
Salarius Pharmaceuticals Cites Errors on S&P CapIQ Platform Following Merger with Decoy Therapeutics, Affirms Its Shares Continue to Trade on the Nasdaq Stock Market Under the Symbol “SLRX”
19/11/2025
Company has pro forma cash of approximately $14 million following recent public offering HOUSTON and CAMBRIDGE, Mass., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX) (Salarius or the [...]
The American Society of Pain and Neuroscience (ASPN) Issues Consensus Guidelines on Peripheral Nerve Stimulation
19/11/2025
- Guidelines support increasing treatment access for patients given the clinical evidence in addressing chronic pain - CLEVELAND, Nov. 19, 2025 (GLOBE NEWSWIRE) -- The American Society of Pain and Neuroscience (ASPN) [...]
ZIRCON-X Analysis: TLX250-CDx Impacts Clinical Decision Making for Almost Half of Patients with Indeterminate Renal Masses
19/11/2025
MELBOURNE, Australia and INDIANAPOLIS, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces results from the ZIRCON-X study which finds that almost half of all [...]
Protext Mobility, Inc. (OTC: TXTM) Provides Shareholder Update
19/11/2025
FORT LAUDERDALE, Fla., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Protext Mobility, Inc. (OTC: TXTM) (“Protext” or the “Company”) is thrilled to share a transformative update that underscores its strategic execution, operational [...]
Higher Purpose Healing Celebrates 110+ 5-Star Google Reviews, Reinforcing Its Role as New Orleans’ Leading Trauma-Informed Healing Center
19/11/2025
Nervous-system–centered energy healing sessions continue to grow in demand as clients seek relief from chronic pain, emotional blocks, and trauma patterns New Orleans, LA , Nov. 19, 2025 (GLOBE NEWSWIRE) -- Higher [...]
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons
19/11/2025
Company Announcement COPENHAGEN, Denmark; November 19, 2025 – Genmab A/S (Nasdaq: GMAB) - In accordance with Article 19 of Regulation No. 596/2014 on Market Abuse and Implementing Regulation 2016/523, this document [...]
Novartis announces plans to build flagship manufacturing hub in North Carolina
19/11/2025
Expansion represents significant investment in North Carolina and is expected to create 700 new jobs in the state by end of 2030 Enables manufacturing of medicines across company’s main therapeutic areas in one [...]
Novartis announces plans to build flagship manufacturing hub in North Carolina
19/11/2025
Expansion represents significant investment in North Carolina and is expected to create 700 new jobs in the state by end of 2030 Enables manufacturing of medicines across company’s main therapeutic areas in one [...]

Pages